and collagen diseases (Whisnant et al. 1963 , British Medical Journal 1964 , Begg & Simpson 1964 , but I had experience of a case in connection with malaria prophylaxis or suppression in excessive dosage. This patient, who developed neuromyopathy, had for one year been taking 600-900 mg of chloroquine base weekly instead of the recommended 300 mg weekly. She was fully investigated and diagnosed in her native Sweden by Karstorp et al. (1973) .
In view of the widespread use of chloroquine in association with malaria prophylaxis and treatment, and the not inconsiderable problem of side effects from most antimalarial drugs, attention should be drawn to this complication of chloroquine therapy. (October 1982 Journal, p 793 and February 1983, p 161) and Professor Hamilton's letter (January, p. 82). In Februsry 1982 I was involved in another forensic application of this topic, being retained by solicitors for a defendant although I did not examine the plaintiff myself.
Plaintiff and defendant were both drivers of vehicles which collided with each other near traffic lights in July 1979 in Ontario. The plaintiff, who was 17 years old at the time of the accident, suffered head injuries and extensive pelvic fractures, and was delirious and confused subsequent to the accident with a presumed posttraumatic amnesia of at least two hours and probably several days. His first post-traumatic memory was of walking a few steps in the Intensive Care Unit.
He had a retrograde amnesia of some ten to fifteen minutes. The defendant recalled passing through green traffic lights before the accident. The plaintiff could not at first recall the accident, but under hypnosis in May 1981 he' recollected that the same lights were green from him also. Russell & Nathan (1946) in extensive studies of retrograde and post-traumatic amnesia (PTA) established that, with a PTA of one' to twentyfour hours, between 2% and 79% of patients had no retrograde amnesia. Accordingly, it was considered in this case that the probability of the plaintiff having any physical basis for recalling the colour of the traffic lights at the intersection was 7% on the most favourable construction. Russell & Nathan had also studied the recall of memories after head injury with the help of barbiturate hypnosis, in which situation the retrograde amnesia was reduced in 6 out of 40 cases.
The plaintiff was described by the defendant solicitor as a particularly likeable young man with an apparent high degree of integrity. It was thought that a jury might well wish to accept his evidence and that of the doctor who had helped him 'recover' his 'memories'. However, in the light of the information presented on retrograde amnesia, the case was settled out of court for a sum approaching $30000.00, which was less than half the amount originally claimed.
I believe the case provides another example of probable confabulation under the influence of hypnosis where it was appropriate to discount the reliability of the supposed memory without impugning the sincerity of the claims.
I It should be noted that the incidence rates in Table 4 for each of weeks 7 through 16 should be adjusted upward to reflect the fact that GBS cases which occurred after 29 January 1977 were not included in the analysis. The GBS rates for weeks one through six were given correctly, starting with an initial denominator for week one of 41485000. With 44 cases reported, the GBS rate for the first week from vaccination was given as (Table 4) , the number at risk at the beginning of the seventh week would be 41484566. However, the effective number at risk during the seventh week must be adjusted to account for the fact that the 2545000 individuals who received the vaccine during the week ending 18 December 1976 (Table I) were not all at risk for the entire seventh week from vaccination. If we assume that each of these vaccinees contributed one-half of a person-week of exposure for the seventh week (Cutler & Ederer 1958) , the effective number at risk for the seventh week would be 41484 566-!(2 545000) = 40212066. The GBS rate for the seventh week from vaccination is then 0.45 per million personweeks, rather than 0.43 as was given in Table 4 . The number at risk at the beginning of the eighth week would then be 41484566- Table 4 . Also, combining weeks 13 through 16 into a single exposure interval, due to the small number of cases reported for these weeks, leads to a GBS rate of 0.32 per million person-weeks for this four-week interval. This number is in close agreement with the estimates computed here for weeks II and 12, and corresponds well with the natural GBS rate of 0.327 per million person-weeks reported by Kennedy et al. (1978) for Olmsted County, Minnesota, during a 42-year period. RICHARD GREENSTREET 31 March 1983 
